UBS Reiterates Neutral Rating on Gentex (GNTX) Ahead of Investor Day

August 20, 2026 10:06 AM

UBS analyst Joseph Spak reiterated a Neutral rating and $25.00 price target on Gentex (NASDAQ: GNTX).The analyst commented, "GNTX will ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found